Seer (SEER) Interest Expenses (2020 - 2026)
Seer (SEER) recorded quarterly Interest Expenses of $68000.0 in Q1 2026, up 51.11% quarter-over-quarter from $45000.0 in Q4 2025, and down 91.03% on a YoY basis from $758000.0 in Q1 2025.
Seer (SEER) Interest Expenses (2020 - 2026) Analysis & Trends
Seer's Interest Expenses history runs 7 years deep, the most recent figure standing at $68000.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 91.03% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $323000.0 (down 70.69% YoY), while the FY2025 annual figure was $1.0 million, up 142.21% from the prior year.
- Interest Expenses was $68000.0 for Q1 2026 at Seer, up from $45000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $758000.0 in Q1 2025 to a low of -$67000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $150562.5 across 5 years, with a median of $73000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses surged 5675.0% in 2023, then slumped 123.34% in 2024.
- A 5-year view of Interest Expenses shows it stood at $73000.0 in 2022, then jumped by 293.15% to $287000.0 in 2023, then plunged by 123.34% to -$67000.0 in 2024, then soared by 167.16% to $45000.0 in 2025, then soared by 51.11% to $68000.0 in 2026.
- The last three Interest Expenses figures came in at $68000.0 (Q1 2026), $45000.0 (Q4 2025), and $210000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -5.58 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 68,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Sep 30, 2025 | 210,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Dec 31, 2024 | -67,000.00 |
| Dec 31, 2024 | -67,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 187,000.00 |
| Jun 30, 2024 | 187,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |